Application time, removal method, and aftercare instructions may vary, so avoid assuming that all products work in the same way
A smaller subset (about 4 to 7% of trial participants) experience GI events severe enough to discontinue
This approach aims to reduce side effects by maintaining more stable drug levels
For extracellular microvesicles, mitophagosomes, and autophagosomes, this release mechanism is dependent on the autophagy pathway (160, 162, 165)
The paucity of data regarding their safety during pregnancy and lactation causes a dilemma for the physician
Injecting at the same time each week keeps those levels as stable as possible, which reduces the likelihood of breakthrough side effects from concentration peaks and valleys